Cisatracurium

Generic Name
Cisatracurium
Brand Names
Nimbex
Drug Type
Small Molecule
Chemical Formula
C53H72N2O12
CAS Number
96946-41-7
Unique Ingredient Identifier
QX62KLI41N
Background

Cisatracurium is a non-depolarising neuromuscular blocking agent of the benzylisoquinolinium class, available in its salt form, cisatracurium besylate. Cisatracurium has an intermediate duration of action and is one of the most commonly used neuromuscular blocking agents in intensive care.. Cisatracurium acts on cholinergic receptors, blocking neuromuscular ...

Indication

Cisatracurium is indicated as an adjunct to general anesthesia to facilitate tracheal intubation in adults and pediatric patients 1 month to 12 years of age. Cisatracurium is also indicated to provide skeletal muscle relaxation during surgery in adults and pediatric patients 2 to 12 years of age as a bolus or infusion maintenance and for mechanical ventilati...

Associated Conditions
-
Associated Therapies
General Anesthesia, Skeletal muscle relaxation for mechanical ventilation, Smooth muscle relaxation prior to radiological procedures therapy

Effect of Different Depths of Neuromuscular Blockade on Respiratory Mechanics in Patients With Moderate-severe Acute Respiratory Distress Syndrome

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2024-07-23
Last Posted Date
2024-07-23
Lead Sponsor
Southeast University, China
Target Recruit Count
20
Registration Number
NCT06514209
Locations
🇨🇳

Zhongda Hospital, Affiliated to Southeast University, Nanjing, Jiangsu, China

Median Effective Dose of Cisatracurium for the Prevention of Fasciculation Caused by the Injection of Succinylcholine

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2023-03-09
Last Posted Date
2023-03-09
Lead Sponsor
Yangzhou University
Target Recruit Count
90
Registration Number
NCT05760976
Locations
🇨🇳

the Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, China

Muscle Relaxants and Laryngeal Local Anesthetics for Laryngeal Mask Airway Insertion Decreasing Propofol in Elderly

First Posted Date
2022-04-04
Last Posted Date
2024-02-06
Lead Sponsor
Chang Gung Memorial Hospital
Target Recruit Count
96
Registration Number
NCT05310110
Locations
🇨🇳

Linkup Chang Gung Memorial Hospital, Taoyuan City, Taiwan

An Observational Study of Cisatracurium 0.15 mg/kg in Young and Elderly (≥ 80 Years) Patients.

First Posted Date
2021-06-10
Last Posted Date
2022-01-26
Lead Sponsor
Matias Vested
Target Recruit Count
60
Registration Number
NCT04921735
Locations
🇩🇰

Rigshospitalet, Copenhagen, Denmark

Evaluation of Residual Neuromuscular Blockade and of Late Recurarization in the Post Anesthesia Care Unit in Patients Undergoing Videolaparoscopic Cholecystectomy

Completed
Conditions
Interventions
First Posted Date
2019-02-06
Last Posted Date
2019-02-06
Lead Sponsor
Federal University of Minas Gerais
Target Recruit Count
85
Registration Number
NCT03831815
Locations
🇧🇷

Universidade Federal de Minas Gerais, Faculdade de Medicina, Departamento de Cirurgia., Belo Horizonte, Minas Gerais, Brazil

Is it Possible to Replace Fentanyl in Anesthesia for Minor Procedures?

First Posted Date
2019-01-16
Last Posted Date
2019-01-16
Lead Sponsor
Ain Shams University
Target Recruit Count
120
Registration Number
NCT03806374
Locations
🇪🇬

Ain Shams University hospitals, Cairo, Egypt

The Study of Pharmacokinetics and Pharmacodynamics of Cisatracurium

First Posted Date
2017-11-09
Last Posted Date
2019-03-06
Lead Sponsor
Mahidol University
Target Recruit Count
10
Registration Number
NCT03337373
Locations
🇹🇭

Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand

Etomidate to Improve Outcome in Elderly Patients

First Posted Date
2016-09-21
Last Posted Date
2020-12-10
Lead Sponsor
Zhihong LU
Target Recruit Count
1917
Registration Number
NCT02910206
Locations
🇨🇳

Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China

© Copyright 2024. All Rights Reserved by MedPath